HCC Trials: Insights from the LAUNCH, EMERALD-1, and LEAP-012 Trials

Opinion
Video

Medical experts discuss the LAUNCH study, EMERALD-1, and LEAP-012 trials, providing updates on the progress and findings that influence the treatment paradigm for hepatocellular carcinoma.

Related Videos
A panel of 4 experts on colorectal cancer
A panel of 4 experts on colorectal cancer
Video 6 - "Shared Decision Making and Multidisciplinary Collaboration in the Evolving HR+/HER2- Early-Stage Breast Cancer Landscape"
Related Content
Karim Chamie, MD

N-803/BCG Approval Signals Paradigm Shift in Management of BCG-Unresponsive NMIBC

May 1st 2024
Article
Stephanie L. Graff, MD, director, Breast Oncology, Lifespan Cancer Institute, associate professor, medicine, Brown University; Reshma L. Mahtani, DO, medical oncologist, Miami Cancer Institute, chief, Breast Medical Oncology, Baptist Health’s Wellness and Medical Complex; Kelly E. McCann, MD, PhD, breast medical oncologist, assistant clinical professor, medicine, the University of California, Los Angeles Health David Geffen School of Medicine; Hope S. Rugo, MD, Winterhof Family Endowed Professor in Breast Cancer, the University of California San Francisco (UCSF), professor, medicine, Division of Hematology and Oncology, director, Breast Oncology, director, Clinical Trials Education, director, Cancer Infusion Services, the UCSF Helen Diller Family Comprehensive Cancer Center

Breast Cancer Experts Share Obstacles and Successes as Women in Oncology

April 11th 2024
Podcast
John D. Gordan, MD, PhD

ASCO Updates Advanced HCC Treatment Guideline

April 29th 2024
Article
Zev A. Wainberg, MD, professor, medicine, the University of California, Los Angeles (UCLA), codirector, the UCLA Gastrointestinal Oncology Program

FDA Approval Insights: NALIRIFOX in Metastatic Pancreatic Cancer

March 11th 2024
Podcast
Michael Iglesia, MD, PhD

Iglesia Spotlights the Current Complexities of Treatment Sequencing in Advanced HCC

April 5th 2024
Article
Rachna T. Shroff, MD, MS, FASCO

ASCO GI Updates Provide Window Into Evolving HCC Treatment Paradigm

March 28th 2024
Article